The Saudi Arabia pharmacy retail market was valued at USD 30.32 Billion in 2025 and is expected to grow at a CAGR of 8.30%, reaching USD 67.30 Billion by 2035. The market growth is driven by the growing healthcare demand and regulatory reforms in Saudi Arabia.
Base Year
Historical Period
Forecast Period
Liberalized foreign ownership rules are set to attract global pharmacy chains, enhancing competition and accelerating retail market growth.
Planned expansion of major pharmacy networks will increase accessibility and strengthen Saudi Arabia’s pharmacy retail infrastructure significantly.
Regulatory reforms combined with rising investments in healthcare modernization position the pharmacy retail sector for robust long-term growth.
Compound Annual Growth Rate
8.3%
Value in USD Billion
2026-2035
*this image is indicative*
The market is witnessing steady growth, driven by an expanding healthcare infrastructure, increasing chronic disease prevalence, and a shift toward modern retail formats. Rising health awareness and government initiatives under Vision 2030 are promoting digitalization and e-pharmacy adoption. Additionally, strong demand for prescription medications, coupled with improving access to advanced therapies, supports market expansion. The dominance of offline pharmacies persists, though online channels are gaining momentum, reflecting evolving consumer preferences and the integration of technology into pharmaceutical distribution systems. The market is expected to grow at a CAGR of 8.30% during the forecast period of 2026-2035 and attain a market value of USD 67.30 Billion by 2035.
Strategic Expansion Poised to Drive Saudi Arabia Pharmacy Retail Growth
The aging population and Vision 2030’s healthcare modernization agenda are key catalysts shaping Saudi Arabia’s pharmacy retail market. For instance, in September 2024, Aster DM Healthcare, in partnership with Al Hokair Holding Group, announced plans to open 250 new pharmacies across Saudi Arabia over five years, starting in Riyadh and integrating high-street and mall locations. This expansion will significantly improve geographic access to healthcare products while establishing a strong retail infrastructure. By enhancing product availability and convenience, this initiative is expected to accelerate market growth and elevate patient reach throughout the forecast period.
Major market trends include regulatory liberalization and retail chain expansion.
Liberalization of Foreign Ownership Accelerating Retail Pharmacy Market Growth
The Saudi pharmacy retail sector is witnessing a transformative shift driven by liberalized investment policies and increasing foreign participation. For instance, in May 2025, Saudi Arabia officially opened its retail pharmacy sector to foreign investors, removing ownership restrictions to attract international chains. This regulatory reform encourages global players to establish operations in the Kingdom, fostering competition, improving service standards, and expanding consumer choices. Consequently, these measures are poised to accelerate market growth by strengthening capital inflow, expanding retail infrastructure, and aligning with Vision 2030’s healthcare development agenda.
Drugs to Dominate the Segment by Product Type
The drugs segment is expected to hold the largest share of the market by product type. This dominance stems from the rising prevalence of chronic diseases such as diabetes and cardiovascular disorders, which significantly increase prescription medicine demand. Additionally, the country’s aging population and expansion of healthcare coverage further boost prescription drug utilization. Historically, drugs accounted for about 65% of market revenue, underscoring their critical role in healthcare. With government initiatives improving medication access, this segment will likely maintain its leadership throughout the forecast period.
The key features of the market report comprise funding and investment analysis, and strategic initiatives by the leading players. The major companies in the market are as follows:
Founded in 1986 and headquartered in Jeddah, Nahdi Medical Company is Saudi Arabia’s largest and most beloved retail pharmacy chain. It operates over 1,100 pharmacies across more than 140 cities and villages. Listed on the Saudi Exchange since March 2022, Nahdi integrates advanced digital capabilities—including omnichannel services, express clinics, e-pharmacist consultations, and a smart distribution center (IMDAD) to ensure high availability and swift delivery.
Established in Al-Khobar in 1993, Al-Dawaa has grown into a key player in Saudi’s pharmacy retail, operating over 900 high-quality pharmacies across more than 130 cities. Listed on the Saudi Exchange since March 2022, the company emphasizes well-trained pharmacists, spacious store layouts, and educational consumer engagement. Strategically, Al-Dawaa has also partnered with global firms to localize medical device production, supporting domestic capacity and Saudi Vision 2030.
Based in Jeddah, United Pharmaceuticals Company (also known as United Pharmacies) is among the oldest and most recognized retail pharmacy chains in Saudi Arabia, with a network spanning many major cities including Jeddah, Mecca, Taif, Riyadh, Medina, and Abha. Founded in 1990, UPC has earned a reputation for high-quality healthcare services and a strong internal culture, evidenced by its 2025 “Best Place to Work in Saudi Arabia” award from Great Place to Work.
Planet Pharmacies is a joint venture between Global and Julphar Pharmaceuticals, one of the Middle East’s largest generic drug manufacturers. Established in 2007, the retailer spans over 150 stores across its key markets, including Saudi Arabia, UAE, and Oman. Through Julphar’s full acquisition of Planet, the company now offers an end-to-end pharmaceutical value chain, from manufacturing and distribution to retail—enhancing efficiencies, pricing, and market reach.
*Please note that this is only a partial list; the complete list of key players is available in the full report. Additionally, the list of key players can be customized to better suit your needs.*
Other key players in the market include Innova Pharmacies, Seha Pharmacies and Tadawi Pharmacy.
The market report offers a detailed analysis of the market based on the following segments:
Market Breakup by Type
Market Breakup by Product Type
Market Breakup by Mode of Purchase
Market Breakup by Category
Upto 15% Off
USD
$1999 $1799
$3099 $2789
$4599 $3909
$5999 $5099
*While we strive to always give you current and accurate information, the numbers depicted on the website are indicative and may differ from the actual numbers in the main report. At Expert Market Research, we aim to bring you the latest insights and trends in the market. Using our analyses and forecasts, stakeholders can understand the market dynamics, navigate challenges, and capitalize on opportunities to make data-driven strategic decisions.*
Get in touch with us for a customized solution tailored to your unique requirements and save upto 35%!
Explore our key highlights of the report and gain a concise overview of key findings, trends, and actionable insights that will empower your strategic decisions.
| REPORT FEATURES | DETAILS |
| Base Year | 2025 |
| Historical Period | 2019-2025 |
| Forecast Period | 2026-2035 |
| Scope of the Report |
Historical and Forecast Trends, Industry Drivers and Constraints, Historical and Forecast Market Analysis by Segment:
|
| Breakup by Type |
|
| Breakup by Product Type |
|
| Breakup by Mode of Purchase |
|
| Breakup by Category |
|
| Market Dynamics |
|
| Supplier Landscape |
|
| Companies Covered |
|
Datasheet
One User
USD 1,999
USD 1,799
tax inclusive*
Single User License
One User
USD 3,099
USD 2,789
tax inclusive*
Five User License
Five User
USD 4,599
USD 3,909
tax inclusive*
Corporate License
Unlimited Users
USD 5,999
USD 5,099
tax inclusive*
*Please note that the prices mentioned below are starting prices for each bundle type. Kindly contact our team for further details.*
Flash Bundle
Small Business Bundle
Growth Bundle
Enterprise Bundle
*Please note that the prices mentioned below are starting prices for each bundle type. Kindly contact our team for further details.*
Flash Bundle
Number of Reports: 3
20%
tax inclusive*
Small Business Bundle
Number of Reports: 5
25%
tax inclusive*
Growth Bundle
Number of Reports: 8
30%
tax inclusive*
Enterprise Bundle
Number of Reports: 10
35%
tax inclusive*
How To Order
Select License Type
Choose the right license for your needs and access rights.
Click on ‘Buy Now’
Add the report to your cart with one click and proceed to register.
Select Mode of Payment
Choose a payment option for a secure checkout. You will be redirected accordingly.
Gain insights to stay ahead and seize opportunities.
Get insights & trends for a competitive edge.
Track prices with detailed trend reports.
Analyse trade data for supply chain insights.
Leverage cost reports for smart savings
Enhance supply chain with partnerships.
Connect For More Information
Our expert team of analysts will offer full support and resolve any queries regarding the report, before and after the purchase.
Our expert team of analysts will offer full support and resolve any queries regarding the report, before and after the purchase.
We employ meticulous research methods, blending advanced analytics and expert insights to deliver accurate, actionable industry intelligence, staying ahead of competitors.
Our skilled analysts offer unparalleled competitive advantage with detailed insights on current and emerging markets, ensuring your strategic edge.
We offer an in-depth yet simplified presentation of industry insights and analysis to meet your specific requirements effectively.
Share